(2S)-1-CYCLOHEXYL-4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]-2-METHYL-2-PHENYL-1-BUTANONE
Compound with spectra: 1 NMR
![(2S)-1-CYCLOHEXYL-4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]-2-METHYL-2-PHENYL-1-BUTANONE](/api/compound/JB9CPWkqAlu.png?ph=true&h=300&w=458 "(2S)-1-CYCLOHEXYL-4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]-2-METHYL-2-PHENYL-1-BUTANONE")
| SpectraBase Compound ID | JB9CPWkqAlu |
|---|---|
| InChI | InChI=1S/C28H38N2O2/c1-28(24-13-7-4-8-14-24,27(31)23-11-5-3-6-12-23)17-18-29-19-21-30(22-20-29)25-15-9-10-16-26(25)32-2/h4,7-10,13-16,23H,3,5-6,11-12,17-22H2,1-2H3/t28-/m1/s1 |
| InChIKey | GXVHRYDXBSTHCF-MUUNZHRXSA-N |
| Mol Weight | 434.6 g/mol |
| Molecular Formula | C28H38N2O2 |
| Exact Mass | 434.293328 g/mol |
| Enantiomer InChIKey | GXVHRYDXBSTHCF-NDEPHWFRSA-N |
| Racemate InChIKey | GXVHRYDXBSTHCF-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO |
(2S)-1,2-DIPHENYL-4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]-2-METHYL-1-BUTANONE
1-(2-Methoxyphenyl)-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine
1-[.beta.-(4-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-5-yl)ethyl]-4-(o-methoxyphenyl)piperazine
1-[(4-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl)methyl]-4-(o-methoxyphenyl)piperazine
2,3,4,5-Tetrahydro-N-[3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl]benzo[c]azepin-1-one
1-[4-(2-methoxyphenyl)piperazin-1-yl]-2-oxidanyl-2,2-diphenyl-ethanone
4-(3-Methoxyphenyl)-2-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]thiazole
methyl 2-(4-{[1-(2-thienylsulfonyl)-4-piperidinyl]carbonyl}-1-piperazinyl)phenyl ether
1-[1-(2-Methoxyphenyl)piperazin-4-yl]-3-(4-hydroxy-1-naphthyloxy)-2-propanol Dihydrochloride
1-(2-methoxyphenyl)-4-[(2E)-3-(4-methoxyphenyl)-2-phenyl-2-propenoyl]piperazine
| Title | Journal or Book | Year |
|---|---|---|
| Asymmetric Construction of Quaternary Centers by Enantioselective Allylation: Application to the Synthesis of the Serotonin Antagonist LY426965 | Organic Letters | 2002 |